Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

ATH-063 is a novel, oral, first-in-class, small molecule therapeutic targeting both inflammation and direct mucosal healing in patients with ulcerative colitis and Crohn's disease LOS ANGELES, CA / ...

Junevity, a biotechnology company on a mission to extend lifespan and healthspan with cell reprogramming, today announced the publication of a peer-reviewed study in Proceedings of the National ...

The Cancer Biomarkers Market is poised for robust expansion driven by escalating industry demand, accelerated technological innovation, and expanding clinical adoption. Rising global cancer ...

“The projects awarded pilot studies grants for 2026 address important clinical and translational science questions,” says CTSI Director Sanjay Sethi, MD, SUNY Distinguished Professor of medicine and ...

Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining different types of biological data, like genomics and other ‘omics’, will become ...

What Is Driving the Updated Illumina Price Target? Illumina's fair value estimate has been revised from about US$119.84 to ...

The best rowing machines have a few things in common: They have superior ergonomics, good construction, and they’re easy—and especially safe—to use. When testing rowing machines, Consumer Reports ...